Replies to post #430320 on Amarin Corp Plc (AMRN)

[rosemountbomber]

SD, good question. No question that I am somewhat unhappy/frustrated about PFE's price movement.

First let me say that I don't know what is really going on behind the scenes with Starboard, Bourla, and others in the boardroom, so I will confine my thoughts to other things. I will give an example at the end of this but no question PFE is out of favor with investors and that is also partly because many are chasing momentum stocks. Like you say, they had great earnings this past qtr and the next qtr will be great in comparison to the same qtr last year. They have been cutting expenses, which is good and have almost 60 drugs in either phase II or phase III trials. No question I should have taken some or all off the table when they hit $60 almost exactly 3 years ago, but dumb me.

In Feb, Mar, April of this year I bought BMY in the high 40's and low 50's. It proceeded to go down (looking like another PFE) and in July I bought more at $40. Well, BMY has turned it around in the last month and today, after ABBV announced that their schizo drug missed targets, the stock jumped to $60. For quite a while things looked just as dire for BMY. I guess my experience with BMY this year has not only given me hope for the future of PFE but kept me calm while watching it go down. So, right now, I am sticking with PFE (and sucking up the divvy in the meantime) assuming and thinking that its time will come. With all those drugs in trials some have to hit just as some will fail.

When I look at my Fidelity site and the research section on PFE I see most if not all analysts rating it highly (that does scare me a tiny bit) and they have a thing called Trefis Valuation Estimate (have no idea what that is) and it pegs fair value at this very instant at $36.22. That is about $10 higher than the stock closed today. I don't presume to know how to unlock the value there, but I definitely think there is more value in the company than $26 a share. Plus if we expect interest rates to continue to come down the 6%+ div should ultimately drive investors looking for yield into the stock. Hope this didn't sound to rosy. I guess you didn't catch me on a bad day. Are your thoughts on PFE much different?